HTO Q1 2026 Earnings EPS Surpasses Estimates with 533 Beat BWNB Q1 2026 Earnings Significant EPS Miss Highlights Persistent Cost Pressures SNDL Q1 2026 Earnings NarrowerThanExpected Loss as Company Navigates Cannabis Market Challenges SWIM Q1 2026 Earnings Loss Narrower Than Expected as Cost Controls Take Hold Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline HNI Q1 2026 Earnings EPS Beat Offers Profitability Signal Amid Quiet Revenue Disclosures